The Federal Board of Revenue (FBR) in Pakistan announced on Monday the grant of duty exemption on the import of critical oxygen-related goods.
This measure is aimed at ensuring an unhindered supply of essential medical equipment and oxygen to combat the spread of COVID-19.
The FBR issued SRO 552(I)/2021, providing a legal framework for the duty-free import of specified goods related to oxygen. The duty exemption is applicable for a period of eighty days, effective from May 14, 2021. This timeline aligns with the urgency and ongoing efforts to address the healthcare challenges posed by the pandemic.
The following goods, identified by their Pakistan Customs Tariff (PCT) codes, have been granted exemption from the levy of customs duty:
1. Oxygen Gas (PCT Code: 2804.4000)
2. Cylinders for Oxygen Gas (PCT Code: 7311.0090)
3. Cryogenic Tanks for Oxygen Gas (PCT Code: 7311.0030)
4. Oxygen Manufacturing Plant (PCT Code: 8405.1000)
5. Oxygen Concentrator/Generator (PCT Code: 9019.2090)
The duty exemption encompasses a range of critical equipment and materials necessary for the production, storage, and distribution of oxygen – a vital component in treating severe cases of COVID-19. Oxygen concentrators, cylinders, and manufacturing plants are integral to the healthcare infrastructure’s ability to provide life-saving medical support to patients affected by the virus.
The FBR’s decision reflects a coordinated effort to facilitate the importation of essential supplies required to manage the escalating healthcare crisis. By waiving customs duties on these specified goods, the government aims to streamline and expedite the import process, ensuring that healthcare facilities have access to the necessary equipment without financial barriers.
The exemption is part of a broader strategy to enhance the capacity of healthcare systems and address the surge in demand for medical resources during the pandemic. The inclusion of cryogenic tanks further underscores the commitment to securing the entire supply chain for oxygen-related needs.
As the nation grapples with the evolving challenges posed by the pandemic, the duty exemption is a targeted intervention to fortify the healthcare sector’s resilience. It aligns with global efforts to ensure the unimpeded flow of essential medical supplies and emphasizes the collaborative approach required to combat the public health crisis.
Stakeholders in the healthcare industry, including manufacturers, distributors, and healthcare providers, are encouraged to leverage this duty exemption to bolster their efforts in mitigating the impact of COVID-19. The FBR’s initiative underscores the government’s commitment to prioritizing public health and safety during these unprecedented times, emphasizing the collective responsibility in navigating the challenges posed by the pandemic.
